Faculty PDF

Programme PDF

Sessions PDF  

6.30: Registration of Delegates. The Clayton Hotel.
    
7.00-7.55: Wound Management

Moderators: Mr. Martin Feeley, FRCSI; Mr. Alun H Davies, M.A., D.M., F.R.C.S. 

07.00: Therapeutic value of hyperbaric oxygen in lower extremity ulcerations.

Dr Francis Rossi, Philip Loori, New Jersey, USA 

07.08: The role of Topical Negative Pressure in wound repair: Overview of evidence based studies.

Ms Chantal Moues, Rotterdam, The Netherlands 

07.20: Topical oxygen alters angiogenesis – related factor expression in chronic diabetic foot ulcers

Dr Gary Scott, Texas, USA 

07.28: Topical Wound Oxygen (TWO2) versus conventional compression dressings in the management of refractory non-healing venous ulcers;  A parallel observational pivotal study

Mr. Wael Tawfick, Niamh Hynes, Sherif Sultan, Galway, Ireland  

07:36: The Mode of Action of Promogran in management of ulcers. Case studies

Ms Fiona Alexander, Dublin, Ireland 

07.44 -07.55: Discussion 

 

 

08.00-09.35: Biomedical Engineering

Moderators: Prof Elliot L. Chaikof  M.D., PhD,, M.D., PhD, Prof Dimitri Mikhailidis BSc MSc MD FASA FFPM FRCP FRCPath 

08.00: Endothelial progenitor cells and their potential clinical applications in peripheral arterial disease

Prof Dimitri Mikhailidis, London, United Kingdom 

08.08: What is the future for tissue engineered vascular grafts?

Prof Bo Risberg, Gothenburg, Sweden 

08.16: Do we need closed cell design in every patient to prevent embolisation:  Design concepts.

Mr. Eamon Brady, Galway, Ireland 

08.24: Nanotechnology in site specific drug delivery stent design. How far are we from the optimal stent.

Prof Elliot L. Chaikof, Atlanta, USA 

08.32: Cardiovascular stent design and vessel stresses: A finite element analysis

Ms Catriona Lally, D Toner, Dublin, Ireland 

08.40: Future directions in embolic protection development, with a focus on the emboshield pro filter.

Mr. Michael Gilvarry, Galway, Ireland 

08.48: The role of Bio-engineering and Moecular Biology in new technology and devices

Ms Kris Kieswetter, Texas, USA 

08.56: Boomerang closure device

Dr Ali Amin, New Jersey, USA 

09.04: THOC: Design concept to Market Product

Mr. Phillip Loori, New Jersey, USA  

09.12: Initial experience using a Sequential Compression Biomechanical Device (SCBD) in Critical Limb Ischaemia (CLI): Non-operative active limb salvage.

Mr. Olubumni Esan, Wael Tawfick, Niamh Hynes, Sherif Sultan, Galway, Ireland  

09.17-09.35: Discussion  

 

 

09.35-10.45: Venous Disease

Moderators: Prof Anthony J. Comerota, M.D., F.A.C.S., Prof Bo Risberg, M.D., Ph.D. 

09.35: Endovascular  therapy of Iliofemoral deep venous thrombosis: Current state of the Art.

Prof Anthony J. Comerota, Ohio, USA 

09.43: Quality of life in Venous Disease

Mr. Alun H. Davies, London, USA 

09.51: Management of chronic venous insufficiency. Percutaneous prosthetic venous valves: current state and possible applications.

Prof Dusan Pavcnik, Oregon, USA 

09.59: Recurrent varicose veins, when to treat or leave alone, The french REVAS experience.

Dr Michel R. Perrin, Decines, France 

10.07: Complications after Varicose vein intervention: The commonest performed surgery and how to avoid litigation.

Mr. Simon Cross, Waterford, Ireland  

10.15: Results of valvuloplasty in patients presenting with deep venous insufficiency and recurrent ulceration

Dr Michel R. Perrin, Decines, France 

10.23: The down slope of Endovenous Laser therapy for primary Varicose Veins. Technology is still lacking

Ms Niamh Hynes, Sherif Sultan, Galway, Ireland  

10.31-10.45: Discussion  

10.45-11.00: Coffee Break 
 

 

11.00-12.45: Peripheral Arterial Disease

Moderators: Sir Peter R.F. Bell, M.D.,F.R.C.S.,D.S.C.,K.B.E., Prof  L. Nelson Hopkins M.D. 

11.00: Platelet inhibition in patients with peripheral vascular disease

Prof Anthony J. Comerota, Toledo, USA 

11.08: Clinical sustained benefit of statins. How can we titrate dose and response in patients with peripheral arterial disease?

Prof Dimitri Mikhailidis, London, United Kingdom 

11.16: Is Subintimal Angioplasty the routine practice for critical lower limb ischaemia: A vascular surgeon’s point of view

Sir Peter R.F. Bell, Leicester, United Kingdom 

11.24: Bailing out during complex subintimal angioplasty

Dr Ali Amin, New Jersey, USA 

11.32: Is distal bypass the routine practice in critical lower limb ischaemia

Mr. Martin Feeley, Dublin, Ireland 

11.40: Combined hybrid techniques in limb salvage

Ms Mary Barry, Dublin, Ireland 

11.48: Results from the Internationl Registry of the AngioSculpt Scoring Balloon for the treatment of Infra-Popliteal Disease

Dr Gary Gershony, Dierk Scheinert, Sherif Sultan, Marc Bosiers, California, USA 

11:56: Does Cilostazol Attenuate Neropathic Symptomatolgy in diabetic patients with Peripheral Arterial Disease?

Dr Mark, O’Donnell, Stephen Badger, Chee V Soon, Belfast, Ireland  

12.04: Scalenus Anterior Resection assessment by disability of arm, should and hand (DASH) scoring in the management of Thoracic Outlet Syndrome

Mr. Max Mahendran, Sherif Sultan, Galway, Ireland 

12.09: Cuffed Synthetic grafts in management of Supragenicular Femoro-Popliteal Arterial Occlusion:  An observational parallel group prospective comparative study in critical lower limb ischaemia (CLI)

.Mr. Wael Tawfick, Niamh Hynes, Sherif Sultan, Galway, Ireland 

12.13: Subintimal angioplasty (SIA) vs Bypass for critical lower limb ischemia in patients with TASC C and D lesions: 5-year result

Ms Niamh Hynes, Sherif Sultan, Galway, Ireland 

12.16: Homocysteine levels, cardiovascular risk factors and complication rates in vascular surgery and endovascular surgery: is there a correlation?

Dr Helen Heneghan, Wael Tawfick, Sherif Sultan, Galway, Ireland  

12.21: The effects of cilostazol on glucose and lipid homeostasis in claudicating patients with diabetes and impaired 

Dr Mark O’Donnell, Stephen Badger, Chee V Soong, Belfast, Ireland  

12.29-12.40: Discussion 

12.40-13.40 Lunch  

 

 

13.40-15.30: Carotid Artery Disease

Moderators: Prof Mark D. Morasch, M.D, Prof Peter Gaines, FRCP, FRCR 

13.40: Anesthetic choice for Carotid Surgery and the myth of high risk

Prof Jerry Goldstone, Cleveland, USA 

13.48: How do the results of SPACE and EVA-3S affect the future of carotid artery stenting: The Sheffield point of view

Prof Peter Gaines, Sheffield, United Kingdom 

13.56: Is It Justified And Ethical To Perform CAS In Asymptomatic Patients/octagenarians? 

Ms Alison Halliday, London, United Kingdom 

14.04: A Surgeon’s Prospective on Carotid Stenting

Mr. Bernard Lee, Belfast, Ireland 

14.12: Microcatheter technique assists stenting of complex carotid stenoses

Mr. Jos van den Berg, Lugano, Switzerland 

14.20: The CASES Post Marketing Surveillance study, involving the PRECISE Stent and ANGIOGUARD

Dr Leo Lawlor, Dublin, Ireland  

14.28: Carotid plaque activity index as an adjuvant tool in planning carotid intervention using duplex ultrasound scan

Prof Luis Mendes Pedro, Lisbon, Portugal 

14.36: Indicatons and timing for treatment in patients with stroke in evolution (both carotid and intracranial disease)

Prof L. Nelson Hopkins, Babak S Jahromi, Buffalo, USA 

14.44: The nature and management of complications in Carotid Artery Stenting

Mr. Jos van den Berg, Lugano, Switzerland 

14.52: Tips in Management of occluded extra cranial ICA or intracranial stenosis in symptomatic carotid artery disease

Prof L. Nelson Hopkins, Babak S Jahromi, Buffalo, USA 

15.00 Clinical predictors of transient ischemic attack, stroke, or death within 30 days of carotid angioplasty and stenting.

 Dr Carlos H Timaran, Dallas, USA 

 

15.08: Carotid artery intervention in High-Risk Patients; A Prospective parallel group observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA).

Ms Niamh Hynes, Sherif Sultan, Galway, Ireland 

15.13-15.30: Discussion 
 

 

 

15.30-16.45: Vascular Training

Moderators: Prof Jerry Goldstone, M.D., F.A.C.S., F.R.C.S., Ed, Mr. Sherif Sultan M.D, FRCS, EBQS-VASC 

15.30: Endovascular training and its impact on the operative experience of vascular trainees in abdominal aortic aneurysm. How much vascular practice volume do we need to give to non main-stream vascular trainee?.

Prof Elliot L. Chaikof, Atlanta, USA 

15.38: Declaring vascular surgery independence: A lot done, a lot to do.

Prof Jerry Goldstone, Cleveland, USA 

15.46:  Irish vascular surgeon training: How to expand their chances of employment and the Educational Rubric under contracted working time directive.

Mr. Martin Feely, Dublin, Ireland  

15.54: Declaration of vascular surgery independence: Are we there yet?

Sir Peter R.F. Bell, Leicester, United Kingdom  

16.02: Deliberate Practice Volume minimises the slope of the learning curve and improves vascular training.

Mr. Sherif Sultan, Galway, Ireland 

16.10: Vascular Surgery Training: The Educational Rubric in America

Prof James C. Stanley, Michigan, USA 

16.18-16.30: Discussion  

16.30-16.45: Coffee Break 

 

16.45-18.15: Aortic Aneurysm Disease

Moderators: Prof James C. Stanley, M.D., Prof Brian R Hopkinson, Ch.M, F.R.C.S. 

16.45: A paradigm shift in interpretation of EVAR II data. Is Intervention the best option in high-risk patients?

Sir Peter R.F. Bell, Leicester, USA 

16.53: Aorfix™ Endograft: A New More Flexible Graft For EVAR: Early Clinical Results in difficult Sharply Angulated Necks and Iliac Anatomy

Prof Brian R Hopkinson, Nottingham, United Kingdom 

17.01: Does the graft make a difference in EVAR?  Which graft should be used to deal with short angulated necks?

Prof Dieter Raithel, Nuremberg, Germany 

17.09: Management of high-risk patient with AAA. Have EVAR II results been misinterpreted. Nationwide Procedural Mortality Statistics Show the Conclusions of EVAR II Do not apply in the USA

Dr Carlos H. Timaran, Prof Frank Veith, EB Rosero, JG Modrall, Dallas, USA 

17.17: An update on the important findings from the EUROSTAR EVAR registry

Mr. Robert Fisher, London, United Kingdom 

17.25: Fenestrated Endografts: Designing and implanting a fenestrated graft: An A-Z guide of technical tips, tools and to avoid disasters

Dr Richard G McWilliams, Liverpool, United Kingdom  

17.33: Pediatric Renovascular Hypertension: Etiology diagnosis and contemporary treatment  

Prof James C Stanley, Ann Arbor, USA 

17.41: Derivation and validation of a customized risk scoring index for Predicting Mortality rate after EVAR or open repair in abdominal aortic aneurysm intervention.

Mr. Chris Beirne, Peter Coyle, Sherif Sultan, Galway, Ireland 

17.46: Efficacy of prostaglandin I2 infusion in the elective open repair of abdominal aortic aneurysm.  A parallel group observational study over a five-year period

Dr Fiachra Martin, Niamh Hynes, Sherif Sultan, Galway, Ireland 

17.51: A prospective observational clinical study and quality adjusted cost-analysis of Open Repair (OP), Endovascular Aortic Repair (EVAR) and Best Medical Treatment alone (BMT) in high-risk patients anatomically suitable for EVAR.  The Irish patient Trial

Ms Niamh Hynes, Sherif Sultan, Galway, Ireland  

17.56-18.15 Discussion:  

 

18.15-19.00: Aortic Aneurysm Disease

Moderators: Prof Michael D. Dake, M.D. Prof Dieter Raithel, M.D., Ph.D.

18.15: Behavior of type one endoleak in Aortic Thoracic endografting. Impact of survellance & secondary intervention on long term outcome.

Prof Mark D Morasch, Chicago, USA 

18.23: Awareness, Diagnosis and Optimal Treatment of Thoracic Aortic Disease: the next frontier in endovascular intervention

Prof Michael D. Dake, Charlottesville, USA 

18.31: Techniques in occluding the aorta during endovascular repair of ruptured abdominal aortic aneurysms

Mr. Bernard Lee, Belfast, Ireland  

18.39: Royal Infirmary of Edinburgh experience with Gore TIPS device.

Dr Hamish Ireland, Edinburgh, Scotland  

18.47: Branched Grafts for Hypogastric Revascularization: Indications and Contraindications

Dr Ignace Tielliu, Eric L.G. Verhoeven, Groningen, The Netherlands

 

18.55:  A parallel group observational study of Supra-Renal Aortic aneurysm Repair (SRAR), Juxtarenal Aneurysm Repair (JRAR) and Infrarenal Aortic Aneurysm Repair (IRAR).  Does Single Suprarenal Artery clamping alter technical and clinical outcome in Para-Renal Aortic Repair?

Ms Niamh Hynes, Sherif Sultan, Galway, Ireland

 

19.00-19.15: Discussion

 

Poster Session:

 

 P1. Computer Modelling to evaluate the hemodynamic effects of intermittent pneumatic compression in patients with critical lower limb ischemia.

Eilish Zaletel, Basma El Homasany, Paul Nolan, Nathan Quinlan, Peter McHugh, Sherif Sultan, Galway, Ireland 

P2: Implementation of the Continuous Auto-Transfusion System (CATS) in Open AAA repair: An Observational Comparative Cohort Study.

Mr Wael Tawfick, Martina O’Connor, Niamh Hynes^, Sherif Sultan. Galway, Ireland. 

P3: Five years experience in Transverse Groin Incision for femoral artery access in arterial reconstructive surgery. A parallel observational longitudinal group comparison study.

Mr. Chris Beirne, Fiachra Martin, Niamh Hynes Sherif Sultan, Galway, Ireland 

P4: Systematic overview of Neuro-protection devices (NPD) during Carotid angioplasty & Stenting (CAS)

Dr Basma El Homasany, Michael Lawlor, Marto Hoary, Niamh Hynes, Sherif Sultan, Galway, Ieland 

P5: Double blinded randomized trial of thin versus ultra-thin Dacron patching in carotid endarterectomy (CEA): short-term technical and clinical outcomeNiamh Hynes, Sherif Sultan.Galway, Ireland

P6: Critical Bleeding in Vascular Surgery; Expanding the Indication of Recombinant Activated Factor VII (rFVIIa)

Wael Tawfick, Martina O’Connor, Brian Manning, Niamh Hynes, Sherif Sultan, Galway, Ireland. 

P7: A prospective feasability study of Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA) in Management of Critical Lower Limb Ischemia (CLI) by Endovascular Revascularisation (EvR).

Ms. Aoife Lowery, Bhasakarapandian  Mahendran, ,Brian J  Manning, Sherif Sultan, Galway, Ireland.  

P8: The influence of a multimodal wound care protocol on incidence of surgical site infections in a specialized vascular unit 

Dr Triona Walshe, Niamh Hynes, Sherif Sultan.